Quintiles.com

  • Assay Development

  • clinical-trials-header
  • Quintiles Clinical Trial

    With the rise of personalized medicine, drug developers are relying more on novel biomarkers to improve their success. 

    Beyond our extensive menu of nearly 400 tests, you may collaborate with our scientists to develop and validate new assays unique to your trial needs.

    Our four assay development laboratories are strategically located in Atlanta, Chicago, Edinburgh and Singapore. Each central lab is fully equipped with state-of-the-art technologies and standardized instrumentation, and staffed by dedicated teams of scientists. You'll find the R&D support you need:  

    • Expertise in fluid,  tissue and cell-based assay development for biomarker testing
    • A robust commitment to developing new and emerging biomarkers, adding approximately 100-150 new assays annually 
    • A range of methodologies to address the specific biomarker and assay development demands of your study 
     

    Through Quintiles' own Translational R&D – Oncology Center of Excellence, our experts in biomarker discovery are providing a better understanding of therapeutic targets, molecular signaling, drug biology and patient response. Those insights add significant value as we develop new assays for your trials.

  • Assay development for novel biomarkers

  • Quintiles Clinical Trails

    Quintiles can ensure the reliability and consistency of your data through our use of a uniform set of validation and standard operating procedures across all of our CAP-accredited laboratories located around the world. Read More

  • Quintiles Clinical Trails

    Advion Bioanalytical Labs provides a full range of immunoassays services, including ELISA assays, for the development and validation of traditional and custom-designed PK, immunogenicity testing, and biomarker projects. Read fact sheet